FASN catalyzes the final step of fatty acid production and is minimally expressed in normal cells but upregulated in ESCC, where it supports tumor survival and is associated with poor prognosis (Zhou et al., 2012; Fhu and Ali, 2020). Here, FASN is linked to neoplasm.